Page last updated: 2024-08-26

u 69593 and Thymus Neoplasms

u 69593 has been researched along with Thymus Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gabrilovac, J; Martin-Kleiner, I1
Bidlack, JM; Joseph, DB; Lawrence, DM2
Bidlack, JM; Martin-Kleiner, I1

Other Studies

4 other study(ies) available for u 69593 and Thymus Neoplasms

ArticleYear
The kappa-opioid agonist U-69593 affects intracellular calcium level in R1.1 mouse thymoma cell line.
    International immunopharmacology, 2002, Volume: 2, Issue:7

    Topics: Analgesics, Opioid; Animals; Benzeneacetamides; Calcium; Intracellular Fluid; Mice; Pyrrolidines; Receptors, Opioid, kappa; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured

2002
Kappa opioid receptors on three related thymoma cell lines. Differences in receptor-effector coupling.
    Advances in experimental medicine and biology, 1995, Volume: 373

    Topics: Adenylyl Cyclases; Analgesics; Animals; Benzeneacetamides; Cell Membrane; GTP Phosphohydrolases; Kinetics; Mice; Pyrrolidines; Receptors, Opioid, kappa; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured

1995
Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling.
    Biochemical pharmacology, 1995, Jan-06, Volume: 49, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Analgesics; Animals; Benzeneacetamides; Benzomorphans; Cell Membrane; GTP Phosphohydrolases; Kinetics; Mice; Pyrrolidines; Receptors, Opioid, kappa; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured

1995
Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity.
    International immunopharmacology, 2001, Volume: 1, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Benzeneacetamides; Down-Regulation; Enzyme Inhibitors; Kinetics; Mice; Pyrrolidines; Receptors, Opioid, kappa; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured

2001